The higher susceptibility of congenital analbuminemic rats to Ca 2+-induced mitochondrial permeability transition is associated with the increased expression of cyclophilin D and nitrosothiol depletion

Molecular Genetics and Metabolism

Volumn 104, Issue 4, 2011, Pages 521-528

  Figueira, Tiago R ^a   Castilho, Roger F ^a   Saito, Ângela ^a   Oliveira, Helena C F ^a   Vercesi, Anibal E ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Analbuminemia; Calcium retention capacity; Dyslipidemia; Hypoalbuminemia; Nagase rats

Indexed keywords

CALCIUM; CALCIUM ION; CYCLOPHILIN D; GLUTATHIONE; HYDROGEN PEROXIDE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; S NITROSOTHIOL;

ANALBUMINEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CALCIUM TRANSPORT; CONTROLLED STUDY; HEART; LIVER; LIVER MITOCHONDRION; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MITOCHONDRION SWELLING; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSITIZATION;

ANIMALS; BRAIN; CALCIUM; CONGENITAL ABNORMALITIES; CYCLOPHILINS; FEMALE; GENE EXPRESSION; LIVER; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MITOCHONDRIAL SWELLING; OXIDATIVE STRESS; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; S-NITROSOTHIOLS; SERUM ALBUMIN;

ANIMALIA; RATTUS;

EID: 82255179426     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.08.031     Document Type: Article

References (68)

1. Peters T. All about Albumin: Biochemistry, Genetics, and Medical Applications 1996, Academic Press, San Diego.
2. Turell L., Carballal S., Botti H., Radi R., Alvarez B. Oxidation of the albumin thiol to sulfenic acid and its implications in the intravascular compartment. Braz. J. Med. Biol. Res. 2009, 42:305-311.
3. Turell L., Botti H., Carballal S., Radi R., Alvarez B. Sulfenic acid-a key intermediate in albumin thiol oxidation. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877:3384-3392.
4. Takahashi M., Kusumi K., Shumiya S., Nagase S. Plasma lipid concentrations and enzyme activities in Nagase analbuminemia rats (NAR). Jikken Dobutsu 1983, 32:39-46.
5. Shaper A.G., Wannamethee S.G., Whincup P.H. Serum albumin and risk of stroke, coronary heart disease, and mortality: the role of cigarette smoking. J. Clin. Epidemiol. 2004, 57:195-202.
6. Schalk B.W., Visser M., Bremmer M.A., Penninx B.W., Bouter L.M., Deeg D.J. Change of serum albumin and risk of cardiovascular disease and all-cause mortality: Longitudinal Aging Study Amsterdam. Am. J. Epidemiol. 2006, 164:969-977.
7. Nagase S., Shimamune K., Shumiya S. Albumin-deficient rat mutant. Science 1979, 205:590-591.
8. Kallee E. Bennhold's analbuminemia: a follow-up study of the first two cases. J. Lab. Clin. Med. 1996, 127:470-480.
9. Kim E.J., Lee A.K., Kim S.H., Kim S.G., Lee M.G. Pharmacokinetics and pharmacodynamics of intravenous azosemide in mutant Nagase analbuminemic rats. Drug Metab. Dispos. 2003, 31:194-201.
10. Minchiotti L., Galliano M., Kragh-Hansen U., Peters T. Mutations and polymorphisms of the gene of the major human blood protein, serum albumin. Hum. Mutat. 2008, 29:1007-1016.
11. Baldo-Enzi G., Baiocchi M.R., Vigna G., Andrian C., Mosconi C., Fellin R. Analbuminaemia: a natural model of metabolic compensatory systems. J. Inherit. Metab. Dis. 1987, 10:317-329.
12. Esumi H., Okui M., Sato S., Sugimura T., Nagase S. Absence of albumin mRNA in the liver of analbuminemic rats. Proc. Natl. Acad. Sci. U.S.A. 1980, 77:3215-3219.
13. Van Tol A., Jansen E.H., Koomans H.A., Joles J.A. Hyperlipoproteinemia in Nagase analbuminemic rats: effects of pravastatin on plasma (apo)lipoproteins and lecithin:cholesterol acyltransferase activity. J. Lipid Res. 1991, 32:1719-1728.
14. Koot B.G., Houwen R., Pot D.J., Nauta J. Congenital analbuminaemia: biochemical and clinical implications. A case report and literature review. Eur. J. Pediatr. 2004, 163:664-670.
15. Newstead J., Card S.E., Lyon A.W. Low serum albumin and abnormal body shape in a young Canadian First Nations woman. Laboratory Medicine 2004, 35. 350-+.
16. Figueira T.R., Vercesi A.E., Oliveira H.C. Lack of plasma albumin impairs intravascular lipolysis and explains the associated free fatty acids deficiency and hypertriglyceridemia. Lipids Health Dis 2010, 9:146.
17. Weinberg J.M. Lipotoxicity. Kidney Int. 2006, 70:1560-1566.
18. Alberici L.C., Oliveira H.C., Bighetti E.J., de Faria E.C., Degaspari G.R., Souza C.T., Vercesi A.E. Hypertriglyceridemia increases mitochondrial resting respiration and susceptibility to permeability transition. J. Bioenerg. Biomembr. 2003, 35:451-457.
19. Alberici L.C., Oliveira H.C., Patricio P.R., Kowaltowski A.J., Vercesi A.E. Hyperlipidemic mice present enhanced catabolism and higher mitochondrial ATP-sensitive K+ channel activity. Gastroenterology 2006, 131:1228-1234.
20. Alberici L.C., Oliveira H.C., Paim B.A., Mantello C.C., Augusto A.C., Zecchin K.G., Gurgueira S.A., Kowaltowski A.J., Vercesi A.E. Mitochondrial ATP-sensitive K(+) channels as redox signals to liver mitochondria in response to hypertriglyceridemia. Free Radic. Biol. Med. 2009, 47:1432-1439.
21. Oliveira H.C., Cosso R.G., Alberici L.C., Maciel E.N., Salerno A.G., Dorighello G.G., Velho J.A., de Faria E.C., Vercesi A.E. Oxidative stress in atherosclerosis-prone mouse is due to low antioxidant capacity of mitochondria. FASEB J. 2005, 19:278-280.
22. Paim B.A., Velho J.A., Castilho R.F., Oliveira H.C., Vercesi A.E. Oxidative stress in hypercholesterolemic LDL (low-density lipoprotein) receptor knockout mice is associated with low content of mitochondrial NADP-linked substrates and is partially reversed by citrate replacement. Free Radic. Biol. Med. 2008, 44:444-451.
23. Lemasters J.J., Theruvath T.P., Zhong Z., Nieminen A.L. Mitochondrial calcium and the permeability transition in cell death. Biochim. Biophys. Acta 2009, 1787:1395-1401.
24. Castilho R.F., Kowaltowski A.J., Meinicke A.R., Bechara E.J., Vercesi A.E. Permeabilization of the inner mitochondrial membrane by Ca2+ ions is stimulated by t-butyl hydroperoxide and mediated by reactive oxygen species generated by mitochondria. Free Radic. Biol. Med. 1995, 18:479-486.
25. Kowaltowski A.J., Castilho R.F., Vercesi A.E. Mitochondrial permeability transition and oxidative stress. FEBS Lett. 2001, 495:12-15.
26. Coelho J.L., Vercesi A.E. Retention of Ca2+ by rat liver and rat heart mitochondria: effect of phosphate, Mg2+, and NAD(P) redox state. Arch. Biochem. Biophys. 1980, 204:141-147.
27. Lehninger A.L., Vercesi A., Bababunmi E.A. Regulation of Ca2+ release from mitochondria by the oxidation-reduction state of pyridine nucleotides. Proc. Natl. Acad. Sci. U.S.A. 1978, 75:1690-1694.
28. Vercesi A.E. Possible participation of membrane thiol groups on the mechanism of NAD(P)+-stimulated Ca2+ efflux from mitochondria. Biochem. Biophys. Res. Commun. 1984, 119:305-310.
29. Valle V.G., Fagian M.M., Parentoni L.S., Meinicke A.R., Vercesi A.E. The participation of reactive oxygen species and protein thiols in the mechanism of mitochondrial inner membrane permeabilization by calcium plus prooxidants. Arch. Biochem. Biophys. 1993, 307:1-7.
30. Vercesi A.E. The participation of NADP, the transmembrane potential and the energy-linked NAD(P) transhydrogenase in the process of Ca2+ efflux from rat liver mitochondria. Arch. Biochem. Biophys. 1987, 252:171-178.
31. Brookes P.S., Salinas E.P., Darley-Usmar K., Eiserich J.P., Freeman B.A., Darley-Usmar V.M., Anderson P.G. Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J. Biol. Chem. 2000, 275:20474-20479.
32. Leite A.C., Oliveira H.C., Utino F.L., Garcia R., Alberici L.C., Fernandes M.P., Castilho R.F., Vercesi A.E. Mitochondria generated nitric oxide protects against permeability transition via formation of membrane protein S-nitrosothiols. Biochim Biophys Acta 2010, 1797:1210-1216.
33. Nguyen T.T.M., Stevens M., Kohr M., Steenbergen S., Murphy E. S-nitrosylation of cyclophilin D alters mitochondrial permeability transition pore. FASEB J. 2011, 25:1031-1033.
34. Kaplan R.S., Pedersen P.L. Characterization of phosphate efflux pathways in rat liver mitochondria. Biochem. J. 1983, 212:279-288.
35. Rosenthal R.E., Hamud F., Fiskum G., Varghese P.J., Sharpe S. Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine. J. Cereb. Blood Flow Metab. 1987, 7:752-758.
36. Kowaltowski A.J., Seetharaman S., Paucek P., Garlid K.D. Bioenergetic consequences of opening the ATP-sensitive K(+) channel of heart mitochondria. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H649-H657.
37. T.R.M. Figueira, A.E. D.R.,Vercesi, R.F. Castilho, Safranine as a fluorescent probe for the evaluation of mitochondrial membrane potential in isolated organelles and permeabilized cells, Methods Mol. Biol. (in press), doi:. doi:10.1007/978-1-61779-382-0_7.
38. Saito A., Castilho R.F. Inhibitory effects of adenine nucleotides on brain mitochondrial permeability transition. Neurochem Res 2010, 35:1667-1674.
39. Zaidan E., Sims N.R. The calcium content of mitochondria from brain subregions following short-term forebrain ischemia and recirculation in the rat. J. Neurochem. 1994, 63:1812-1819.
40. Vacca R.A., Moro L., Caraccio G., Guerrieri F., Marra E., Greco M. Thyroid hormone administration to hypothyroid rats restores the mitochondrial membrane permeability properties. Endocrinology 2003, 144:3783-3788.
41. Shepherd D., Garland P.B. The kinetic properties of citrate synthase from rat liver mitochondria. Biochem. J. 1969, 114:597-610.
42. Teare J.P., Punchard N.A., Powell J.J., Lumb P.J., Mitchell W.D., Thompson R.P. Automated spectrophotometric method for determining oxidized and reduced glutathione in liver. Clin. Chem. 1993, 39:686-689.
43. Jocelyn P.C. Spectrophotometric assay of thiols. Methods Enzymol. 1987, 143:44-67.
44. Kowaltowski A.J., Vercesi A.E., Castilho R.F. Mitochondrial membrane protein thiol reactivity with N-ethylmaleimide or mersalyl is modified by Ca2+: correlation with mitochondrial permeability transition. Biochim. Biophys. Acta 1997, 1318:395-402.
45. Park J.K., Kostka P. Fluorometric detection of biological S-nitrosothiols. Anal. Biochem. 1997, 249:61-66.
46. Joles J.A., Willekes-Koolschijn N., van Tol A., Geelhoed-Mieras M.M., Danse L.H., van Garderen E., Kortlandt W., Erkelens D.W., Koomans H.A. Hyperlipoproteinemia in one-year-old analbuminemic rats. Atherosclerosis 1991, 88:35-47.
47. Lotscher H.R., Winterhalter K.H., Carafoli E., Richter C. Hydroperoxides can modulate the redox state of pyridine nucleotides and the calcium balance in rat liver mitochondria. Proc. Natl. Acad. Sci. U.S.A. 1979, 76:4340-4344.
48. Baines C.P., Kaiser R.A., Purcell N.H., Blair N.S., Osinska H., Hambleton M.A., Brunskill E.W., Sayen M.R., Gottlieb R.A., Dorn G.W., Robbins J., Molkentin J.D. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005, 434:658-662.
49. Giorgio V., Soriano M.E., Basso E., Bisetto E., Lippe G., Forte M.A., Bernardi P. Cyclophilin D in mitochondrial pathophysiology. Biochim Biophys Acta 2010, 1797:1113-1118.
50. Piot C., Croisille P., Staat P., Thibault H., Rioufol G., Mewton N., Elbelghiti R., Cung T.T., Bonnefoy E., Angoulvant D., Macia C., Raczka F., Sportouch C., Gahide G., Finet G., Andre-Fouet X., Revel D., Kirkorian G., Monassier J.P., Derumeaux G., Ovize M. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N. Engl. J. Med. 2008, 359:473-481.
51. Leger P.L., De Paulis D., Branco S., Bonnin P., Couture-Lepetit E., Baud O., Renolleau S., Ovize M., Gharib A., Charriaut-Marlangue C. Evaluation of cyclosporine A in a stroke model in the immature rat brain. Exp Neurol 2011, 230:58-66.
52. Fernstrom M., Tonkonogi M., Sahlin K. Effects of acute and chronic endurance exercise on mitochondrial uncoupling in human skeletal muscle. J. Physiol. 2004, 554:755-763.
53. Csukly K., Ascah A., Matas J., Gardiner P.F., Fontaine E., Burelle Y. Muscle denervation promotes opening of the permeability transition pore and increases the expression of cyclophilin D. J. Physiol. 2006, 574:319-327.
54. Matas J., Young N.T., Bourcier-Lucas C., Ascah A., Marcil M., Deschepper C.F., Burelle Y. Increased expression and intramitochondrial translocation of cyclophilin-D associates with increased vulnerability of the permeability transition pore to stress-induced opening during compensated ventricular hypertrophy. J. Mol. Cell. Cardiol. 2009, 46:420-430.
55. Moro L., Arbini A.A., Hsieh J.T., Ford J., Simpson E.R., Hajibeigi A., Oz O.K. Aromatase deficiency inhibits the permeability transition in mouse liver mitochondria. Endocrinology 2010, 151:1643-1652.
56. King A.L., Swain T.M., Dickinson D.A., Lesort M.J., Bailey S.M. Chronic ethanol consumption enhances sensitivity to Ca(2+)-mediated opening of the mitochondrial permeability transition pore and increases cyclophilin D in liver. Am J Physiol Gastrointest Liver Physiol 2010, 299:G954-966.
57. Naga K.K., Sullivan P.G., Geddes J.W. High cyclophilin D content of synaptic mitochondria results in increased vulnerability to permeability transition. J. Neurosci. 2007, 27:7469-7475.
58. Hazelton J.L., Petrasheuskaya M., Fiskum G., Kristian T. Cyclophilin D is expressed predominantly in mitochondria of gamma-aminobutyric acidergic interneurons. J. Neurosci. Res. 2009, 87:1250-1259.
59. Chouchani E.T., Hurd T.R., Nadtochiy S.M., Brookes P.S., Fearnley I.M., Lilley K.S., Smith R.A., Murphy M.P. Identification of S-nitrosated mitochondrial proteins by S-nitrosothiol difference in gel electrophoresis (SNO-DIGE): implications for the regulation of mitochondrial function by reversible S-nitrosation. Biochem J 2010, 430:49-59.
60. Yamamoto Y., Wakabayashi K., Niki E., Nagao M. Comparison of plasma levels of lipid hydroperoxides and antioxidants in hyperlipidemic Nagase analbuminemic rats, Sprague-Dawley rats, and humans. Biochem. Biophys. Res. Commun. 1992, 189:518-523.
61. Joles J.A., van Goor H., van der Horst M.L., van Tol A., Elema J.D., Koomans H.A. High lipid levels in very low density lipoprotein and intermediate density lipoprotein may cause proteinuria and glomerulosclerosis in aging female analbuminemic rats. Lab. Invest. 1995, 73:912-921.
62. Bourdon E., Loreau N., Blache D. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J. 1999, 13:233-244.
63. Bourdon E., Blache D. The importance of proteins in defense against oxidation. Antioxid. Redox Signal. 2001, 3:293-311.
64. Ishima Y., Kragh-Hansen U., Maruyama T., Otagiri M. Albumin as a nitric oxide-traffic protein: characterization, biochemistry and possible future therapeutic applications. Drug Metab. Pharmacokinet. 2009, 24:308-317.
65. Ishima Y., Akaike T., Kragh-Hansen U., Hiroyama S., Sawa T., Suenaga A., Maruyama T., Kai T., Otagiri M. S-nitrosylated human serum albumin-mediated cytoprotective activity is enhanced by fatty acid binding. J. Biol. Chem. 2008, 283:34966-34975.
66. Minamiyama Y., Takemura S., Inoue M. Albumin is an important vascular tonus regulator as a reservoir of nitric oxide. Biochem. Biophys. Res. Commun. 1996, 225:112-115.
67. Fagian M.M., Pereira-da-Silva L., Martins I.S., Vercesi A.E. Membrane protein thiol cross-linking associated with the permeabilization of the inner mitochondrial membrane by Ca2+ plus prooxidants. J. Biol. Chem. 1990, 265:19955-19960.
68. Teusink B., Voshol P.J., Dahlmans V.E., Rensen P.C., Pijl H., Romijn J.A., Havekes L.M. Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid uptake. Diabetes 2003, 52:614-620.